PhoenixBioPhoenixBio Co.,Ltd.6190東証グロースサービス業FY ending Mar 2026, consolidated, J-GAAP
Out of every ¥100 of sales, about ¥5 is left as operating profit. Revenue changed +1.6% from the prior year, and it swung back to an operating profit.
Net margin × asset turnover = ROA; ROA × financial leverage = ROE
Denominators: average assets and average equity. Derived from reported values; ROE is shown only for positive profit and equity.
| Period | Net margin | Asset turnover | ROA | Financial leverage | ROE |
|---|---|---|---|---|---|
| 2022 | — | —× | -17.0% | —× | — |
| 2023 | 23.2% | 0.80× | 18.6% | 2.24× | 41.8% |
| 2024 | 1.5% | 0.60× | 0.9% | 1.75× | 1.6% |
| 2025 | — | —× | -18.0% | —× | — |
| 2026 | 8.0% | 0.70× | 5.6% | 1.61× | 9.0% |
Financial leverage can raise ROE; a higher value alone does not describe a company's overall condition.
Annual trends in tangible-asset ratios and goodwill balance.
Ratios are derived from reported values. Goodwill is shown only when separately reported; it is not inferred from combined intangible assets. Definition
Track R&D investment and how long operating capital remains tied up before sales turn into cash.
R&D is shown only for years with machine-readable disclosure. Days are estimates using year-end receivables, inventory and payables divided by annual revenue or cost of sales; financial companies are excluded.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Revenue | 1,325 | 2,124 | 1,715 | 1,541 | 1,566 |
| Cost of revenue | 597 | 568 | 520 | 424 | 365 |
| Gross profit | 728 | 1,556 | 1,195 | 1,118 | 1,201 |
| SG&A | 895 | 1,048 | 1,184 | 1,260 | 1,118 |
| Operating income | -168 | 508 | 11 | -142 | 83 |
| Pretax income | -393 | 511 | 60 | -433 | 131 |
| Income tax | -5 | 17 | 33 | 16 | 6 |
| Net income attributable to owners | -388 | 493 | 26 | -449 | 125 |
| Operating margin | -12.7% | 23.9% | 0.6% | -9.2% | 5.3% |
Year-end figures from filings. Unreported items are omitted. Interest-bearing debt excludes lease liabilities.
Each bar totals 100% of assets; other is the residual.
| Item | FY ending Mar 2022 | FY ending Mar 2023 | FY ending Mar 2024 | FY ending Mar 2025 | FY ending Mar 2026 |
|---|---|---|---|---|---|
| Cash and equivalents | ¥1.33B | ¥1.56B | ¥1.38B | ¥1.15B | ¥1.15B |
| Total assets | ¥2.28B | ¥3.02B | ¥2.72B | ¥2.29B | ¥2.19B |
| Net assets | ¥828.2M | ¥1.51B | ¥1.8B | ¥1.37B | ¥1.55B |
| Share capital | ¥2.36B | ¥2.45B | ¥2.56B | ¥2.57B | ¥2.57B |
| Property, plant and equipment | ¥409.7M | ¥538.5M | ¥542.9M | ¥527.7M | ¥518.4M |
| Intangible assets excluding goodwill | ¥1.5M | ¥5.2M | ¥10.9M | ¥18.3M | ¥15M |
| Investment securities | — | ¥125.5M | ¥9.5M | ¥9.4M | ¥10M |
| Current assets | ¥1.85B | ¥2.29B | ¥2.13B | ¥1.72B | ¥1.64B |
| Current liabilities | ¥438.8M | ¥1.29B | ¥421.5M | ¥566.6M | ¥373.3M |
| Short-term borrowings | — | — | ¥100M | ¥100M | ¥110M |
| Long-term borrowings | — | — | ¥300M | ¥220M | ¥140M |
| Total liabilities | ¥1.45B | ¥1.5B | ¥917.7M | ¥919.9M | ¥640.1M |
| Equity attributable to owners of parent | ¥844M | ¥1.52B | ¥1.76B | ¥1.33B | ¥1.46B |
| Retained earnings | -¥2.1B | -¥1.61B | -¥1.58B | -¥2.03B | -¥1.91B |
| Treasury stock | -¥40K | -¥40K | -¥40K | -¥40K | -¥40K |
EDINET (FSA Japan)
有価証券報告書－第25期(2025/04/01－2026/03/31)
EDINET (FSA Japan)
有価証券報告書－第24期(2024/04/01－2025/03/31)
EDINET (FSA Japan)
有価証券報告書－第23期(2023/04/01－2024/03/31)
EDINET (FSA Japan)
有価証券報告書－第22期(2022/04/01－2023/03/31)
EDINET (FSA Japan)
有価証券報告書－第21期(令和3年4月1日－令和4年3月31日)
EDINET (FSA Japan)
有価証券報告書－第20期(令和2年4月1日－令和3年3月31日)
Extracted from XBRL: 46 / Derived from other figures: 1
Spotted an error? Report it (corrections keep the original record)
Markdown with figures, units, periods and sources, ready to paste into ChatGPT or Claude.